Financial disclosures show that Robert F. Kennedy Jr., President Trump's Health and Human Services Secretary nominee, is ...
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback